The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Inflammatory Bowel Disease: A Canadian Burden of Illness Review
Open accessAbstract
BACKGROUND: Inflammatory bowel diseases (IBD) – Crohn’s disease (CD) and ulcerative colitis (UC) – significantly impact quality of life and account for substantial costs to the health care system and society. OBJECTIVE: To conduct a comprehensive review and summary of the burden of IBD that encompasses the epidemiology, direct medical costs, indirect costs and humanistic impact of these diseases in Canada. METHODS: A literature search focused on Canadian data sources. Analyses were applied to the current 2012 Canadian population. RESULTS: There are approximately 233,000 Canadians living with IBD in 2012 (129,000 individuals with CD and 104,000 with UC), corresponding to a prevalence of 0.67%. Approximately 10,200 incident cases occur annually. IBD can be diagnosed at any age, with typical onset occurring in the second or third decade of life. There are approximately 5900 Canadian children <18 years of age with IBD. The economic costs of IBD are estimated to be $2.8 billion in 2012 (almost $12,000 per IBD patient). Direct medical costs exceed $1.2 billion per annum and are driven by cost of medications ($521 million), hospitalizations ($395 million) and physician visits ($132 million). Indirect costs (society and patient costs) total $1.6 billion and are dominated by long-term work losses of $979 million. Compared with the general population, the quality of life patients experience is low across all dimensions of health. CONCLUSIONS: The present review documents a high burden of illness from IBD due to its high prevalence in Canada combined with high per-patient costs. Canada has among the highest prevalence and incidence rates of IBD in the world. Individuals with IBD face challenges in the current environment including lack of awareness of IBD as a chronic disease, late or inappropriate diagnosis, inequitable access to health care services and expensive medications, diminished employment prospects and limited community-based support.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Self-citationEpidemiology of pediatric inflammatory bowel disease: A systematic review of international trends
Benchimol, E. I., Fortinsky, K. J., Gozdyra, P., Van den Heuvel, M., Van Limbergen, J., & Griffiths, A. M. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21349 · Cited by 954
Self-citationThe Epidemiology of Inflammatory Bowel Disease in Canada: A Population-Based Study
Bernstein, C. N., Wajda, A., Svenson, L. W., MacKenzie, A., Koehoorn, M., Jackson, M., Fedorak, R., Israel, D., & Blanchard, J. F. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00603.x · Cited by 636
Self-citationBenchimol, E. I., Guttmann, A., Griffiths, A. M., Rabeneck, L., Mack, D. R., Brill, H., Howard, J., Guan, J., & To, T. (2009) · Gut · doi:10.1136/gut.2009.188383 · Cited by 414
Self-citationJess, T., Riis, L., Vind, I., Winther, K. V., Borg, S., Binder, V., Langholz, E., Thomsen, O. S., & Munkholm, P. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20036 · Cited by 394
Luo, N., Johnson, J. A., Shaw, J. W., Feeny, D., & Coons, S. J. (2005) · Medical Care · doi:10.1097/01.mlr.0000182493.57090.c1 · Cited by 383
Silverstein, M. D., Loftus, E. V., Sandborn, W. J., Tremaine, W. J., Feagan, B. G., Nietert, P. J., Harmsen, W. S., & Zinsmeister, A. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70549-4 · Cited by 354
Self-citationA population-based study of fatigue and sleep difficulties in inflammatory bowel disease
Graff, L. A., Vincent, N., Walker, J. R., Clara, I., Carr, R., Ediger, J., Miller, N., Rogala, L., Rawsthorne, P., Lix, L., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21580 · Cited by 294
Self-citationHospitalisations and surgery in Crohn's disease
Bernstein, C. N., Loftus, E. V., Ng, S. C., Lakatos, P. L., & Moum, B. (2012) · Gut · doi:10.1136/gutjnl-2011-301397 · Cited by 294
Self-citationGraff, L. A., Walker, J. R., Lix, L., Clara, I., Rawsthorne, P., Rogala, L., Miller, N., Jakul, L., McPhail, C., Ediger, J., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.027 · Cited by 292
Self-citation
Cited by
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Self-citationThe global burden of IBD: from 2015 to 2025
Kaplan, G. G. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.150 · Cited by 2,639
The burden of inflammatory bowel disease in Europe
Burisch, J., Jess, T., Martinato, M., & Lakatos, P. L. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.01.010 · Cited by 961
The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
Zuo, T., & Ng, S. C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02247 · Cited by 587
Depression and anxiety in patients with Inflammatory Bowel Disease: a systematic review
Neuendorf, R., Harding, A., Stello, N., Hanes, D., & Wahbeh, H. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.06.001 · Cited by 561
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
Nguyen, G. C., Seow, C. H., Maxwell, C., Huang, V., Leung, Y., Jones, J., Leontiadis, G. I., Tse, F., Mahadevan, U., van der Woude, C. J., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.003 · Cited by 473
Self-citationPast and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data
Coward, S., Clement, F., Benchimol, E. I., Bernstein, C. N., Avina-Zubieta, J. A., Bitton, A., Carroll, M. W., Hazlewood, G., Jacobson, K., Jelinski, S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.002 · Cited by 449
Self-citationBressler, B., Marshall, J. K., Bernstein, C. N., Bitton, A., Jones, J., Leontiadis, G. I., Panaccione, R., Steinhart, A. H., Tse, F., Feagan, B., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.001 · Cited by 413
Self-citationBenchimol, E. I., Bernstein, C. N., Bitton, A., Carroll, M. W., Singh, H., Otley, A. R., Vutcovici, M., El-Matary, W., Nguyen, G. C., Griffiths, A. M., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.97 · Cited by 315
Self-citationUrbanization and the gut microbiota in health and inflammatory bowel disease
Zuo, T., Kamm, M. A., Colombel, J.-F., & Ng, S. C. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0003-z · Cited by 293
Sexton, K. A., Walker, J. R., Graff, L. A., Bernstein, M. T., Beatie, B., Miller, N., Sargent, M., & Targownik, L. E. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001040 · Cited by 79
Mikocka-Walus, A., Bampton, P., Hetzel, D., Hughes, P., Esterman, A., & Andrews, J. M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9580-9 · Cited by 78
“Inflammatory bowel disease (IBD), of which ulcerative colitis (UC), Crohn’s disease (CD) and indeterminate colitis are subtypes, is a chronic relapsing illness of the gastrointestinal tract, affecting 2.2 million people in Europe [1], 1.4 million people in the USA [2], 233,000 in Canada [3] and over 75,000 in Australi…”
BackgroundInfluentialDistance management of inflammatory bowel disease: systematic review and meta-analysis
Huang, V. W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i3.829 · Cited by 75
Adjuvant therapy with antidepressants for the management of inflammatory bowel disease
Mikocka-Walus, A., Prady, S. L., Pollok, J., Esterman, A. J., Gordon, A. L., Knowles, S., & Andrews, J. M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012680.pub2 · Cited by 59
Mokhtar, N. M., Nawawi, K. N. M., Verasingam, J., Zhiqin, W., Sagap, I., Azman, Z. A. M., Mazlan, L., Hamid, H. A., Yaacob, N. Y., Rose, I. M., et al. (2019) · BMC Public Health · doi:10.1186/s12889-019-6858-2 · Cited by 55
Trindade, I. A., Pereira, J., Galhardo, A., Ferreira, N. B., Lucena-Santos, P., Carvalho, S. A., Oliveira, S., Skvarc, D., Rocha, B. S., Portela, F., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.699367 · Cited by 20
Metadata
- Authors
- Rocchi, A., Benchimol, E. I., Bernstein, C. N., Bitton, A., Feagan, B., Panaccione, R., Glasgow, K. W., Fernandes, A., & Ghosh, S.
- Venue
- Canadian Journal of Gastroenterology
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 26
- Issue
- 11
- Pages
- 811-817
- ISSN
- 0835-7900 (ISSN-L)
- OpenAlex
- W1592353726
- Cited by
- 286
- References
- 45
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.